nodes	percent_of_prediction	percent_of_DWPC	metapath
Flunitrazepam—CYP2E1—Fingolimod—multiple sclerosis	0.169	0.212	CbGbCtD
Flunitrazepam—CYP2A6—Prednisolone—multiple sclerosis	0.106	0.133	CbGbCtD
Flunitrazepam—CYP2E1—Mitoxantrone—multiple sclerosis	0.0794	0.0999	CbGbCtD
Flunitrazepam—CYP2A6—Dexamethasone—multiple sclerosis	0.0624	0.0785	CbGbCtD
Flunitrazepam—CYP3A4—Fingolimod—multiple sclerosis	0.0512	0.0644	CbGbCtD
Flunitrazepam—CYP2C19—Prednisone—multiple sclerosis	0.0413	0.052	CbGbCtD
Flunitrazepam—CYP2E1—Dexamethasone—multiple sclerosis	0.0412	0.0518	CbGbCtD
Flunitrazepam—CYP2B6—Dexamethasone—multiple sclerosis	0.0406	0.0511	CbGbCtD
Flunitrazepam—CYP3A4—Methylprednisolone—multiple sclerosis	0.033	0.0415	CbGbCtD
Flunitrazepam—CYP2C19—Dexamethasone—multiple sclerosis	0.0258	0.0325	CbGbCtD
Flunitrazepam—CYP3A4—Triamcinolone—multiple sclerosis	0.025	0.0314	CbGbCtD
Flunitrazepam—CYP3A4—Mitoxantrone—multiple sclerosis	0.0241	0.0303	CbGbCtD
Flunitrazepam—CYP2C9—Dexamethasone—multiple sclerosis	0.0214	0.027	CbGbCtD
Flunitrazepam—CYP3A4—Betamethasone—multiple sclerosis	0.0214	0.027	CbGbCtD
Flunitrazepam—CYP3A4—Prednisolone—multiple sclerosis	0.0212	0.0266	CbGbCtD
Flunitrazepam—CYP3A4—Prednisone—multiple sclerosis	0.02	0.0251	CbGbCtD
Flunitrazepam—CYP3A4—Dexamethasone—multiple sclerosis	0.0125	0.0157	CbGbCtD
Flunitrazepam—Disorientation—Cladribine—multiple sclerosis	0.00219	0.0192	CcSEcCtD
Flunitrazepam—Delusion—Methylprednisolone—multiple sclerosis	0.00189	0.0165	CcSEcCtD
Flunitrazepam—Ataxia—Cladribine—multiple sclerosis	0.00185	0.0161	CcSEcCtD
Flunitrazepam—GABRA6—brainstem—multiple sclerosis	0.00181	0.0533	CbGeAlD
Flunitrazepam—Muscular weakness—Cladribine—multiple sclerosis	0.00173	0.0151	CcSEcCtD
Flunitrazepam—Delusion—Betamethasone—multiple sclerosis	0.00172	0.015	CcSEcCtD
Flunitrazepam—Delusion—Dexamethasone—multiple sclerosis	0.00172	0.015	CcSEcCtD
Flunitrazepam—Hypotension—Fingolimod—multiple sclerosis	0.00159	0.0139	CcSEcCtD
Flunitrazepam—Delusion—Prednisone—multiple sclerosis	0.0015	0.0131	CcSEcCtD
Flunitrazepam—Fatigue—Fingolimod—multiple sclerosis	0.00147	0.0128	CcSEcCtD
Flunitrazepam—Hiccups—Prednisolone—multiple sclerosis	0.00146	0.0127	CcSEcCtD
Flunitrazepam—Hiccups—Triamcinolone—multiple sclerosis	0.00134	0.0117	CcSEcCtD
Flunitrazepam—Hiccups—Methylprednisolone—multiple sclerosis	0.00134	0.0117	CcSEcCtD
Flunitrazepam—Asthenia—Fingolimod—multiple sclerosis	0.00122	0.0107	CcSEcCtD
Flunitrazepam—GABRA2—brainstem—multiple sclerosis	0.00122	0.0359	CbGeAlD
Flunitrazepam—Hiccups—Betamethasone—multiple sclerosis	0.00122	0.0106	CcSEcCtD
Flunitrazepam—Hiccups—Dexamethasone—multiple sclerosis	0.00122	0.0106	CcSEcCtD
Flunitrazepam—GABRA1—brainstem—multiple sclerosis	0.00118	0.0347	CbGeAlD
Flunitrazepam—TSPO—brainstem—multiple sclerosis	0.00113	0.0332	CbGeAlD
Flunitrazepam—Dizziness—Fingolimod—multiple sclerosis	0.00113	0.00983	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Cladribine—multiple sclerosis	0.0011	0.00958	CcSEcCtD
Flunitrazepam—TSPO—retina—multiple sclerosis	0.00109	0.032	CbGeAlD
Flunitrazepam—Headache—Fingolimod—multiple sclerosis	0.00107	0.00931	CcSEcCtD
Flunitrazepam—Malaise—Cladribine—multiple sclerosis	0.00107	0.00931	CcSEcCtD
Flunitrazepam—Hiccups—Prednisone—multiple sclerosis	0.00106	0.00925	CcSEcCtD
Flunitrazepam—Amnesia—Methylprednisolone—multiple sclerosis	0.00103	0.00903	CcSEcCtD
Flunitrazepam—Anxiety—Cladribine—multiple sclerosis	0.001	0.00876	CcSEcCtD
Flunitrazepam—Discomfort—Cladribine—multiple sclerosis	0.000994	0.00868	CcSEcCtD
Flunitrazepam—Drowsiness—Mitoxantrone—multiple sclerosis	0.000994	0.00868	CcSEcCtD
Flunitrazepam—Confusional state—Cladribine—multiple sclerosis	0.000973	0.00849	CcSEcCtD
Flunitrazepam—Sweating—Mitoxantrone—multiple sclerosis	0.000953	0.00832	CcSEcCtD
Flunitrazepam—GABRA6—nervous system—multiple sclerosis	0.000949	0.0279	CbGeAlD
Flunitrazepam—Psychotic disorder—Methylprednisolone—multiple sclerosis	0.000949	0.00828	CcSEcCtD
Flunitrazepam—Tachycardia—Cladribine—multiple sclerosis	0.000942	0.00822	CcSEcCtD
Flunitrazepam—Dysarthria—Methotrexate—multiple sclerosis	0.000936	0.00817	CcSEcCtD
Flunitrazepam—Muscular weakness—Prednisolone—multiple sclerosis	0.000934	0.00815	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Cladribine—multiple sclerosis	0.000933	0.00814	CcSEcCtD
Flunitrazepam—Irritability—Methylprednisolone—multiple sclerosis	0.000927	0.00809	CcSEcCtD
Flunitrazepam—GABRA5—nervous system—multiple sclerosis	0.000921	0.0271	CbGeAlD
Flunitrazepam—GABRA6—central nervous system—multiple sclerosis	0.000914	0.0269	CbGeAlD
Flunitrazepam—Hypotension—Cladribine—multiple sclerosis	0.000902	0.00787	CcSEcCtD
Flunitrazepam—GABRA6—cerebellum—multiple sclerosis	0.000893	0.0263	CbGeAlD
Flunitrazepam—Ill-defined disorder—Azathioprine—multiple sclerosis	0.000892	0.00779	CcSEcCtD
Flunitrazepam—GABRA5—central nervous system—multiple sclerosis	0.000887	0.0261	CbGeAlD
Flunitrazepam—Malaise—Azathioprine—multiple sclerosis	0.000867	0.00757	CcSEcCtD
Flunitrazepam—Psychotic disorder—Betamethasone—multiple sclerosis	0.000863	0.00753	CcSEcCtD
Flunitrazepam—Psychotic disorder—Dexamethasone—multiple sclerosis	0.000863	0.00753	CcSEcCtD
Flunitrazepam—Muscular weakness—Triamcinolone—multiple sclerosis	0.000859	0.0075	CcSEcCtD
Flunitrazepam—Somnolence—Cladribine—multiple sclerosis	0.000858	0.00749	CcSEcCtD
Flunitrazepam—GABRA3—nervous system—multiple sclerosis	0.000857	0.0252	CbGeAlD
Flunitrazepam—Muscular weakness—Methylprednisolone—multiple sclerosis	0.000857	0.00748	CcSEcCtD
Flunitrazepam—Irritability—Dexamethasone—multiple sclerosis	0.000843	0.00736	CcSEcCtD
Flunitrazepam—Irritability—Betamethasone—multiple sclerosis	0.000843	0.00736	CcSEcCtD
Flunitrazepam—GABRA4—nervous system—multiple sclerosis	0.000835	0.0246	CbGeAlD
Flunitrazepam—Fatigue—Cladribine—multiple sclerosis	0.000832	0.00726	CcSEcCtD
Flunitrazepam—GABRA3—central nervous system—multiple sclerosis	0.000825	0.0243	CbGeAlD
Flunitrazepam—GABRA1—medulla oblongata—multiple sclerosis	0.000821	0.0242	CbGeAlD
Flunitrazepam—Amnesia—Prednisone—multiple sclerosis	0.000819	0.00715	CcSEcCtD
Flunitrazepam—Discomfort—Azathioprine—multiple sclerosis	0.000809	0.00706	CcSEcCtD
Flunitrazepam—GABRA4—central nervous system—multiple sclerosis	0.000804	0.0237	CbGeAlD
Flunitrazepam—Feeling abnormal—Cladribine—multiple sclerosis	0.000795	0.00694	CcSEcCtD
Flunitrazepam—TSPO—medulla oblongata—multiple sclerosis	0.000787	0.0231	CbGeAlD
Flunitrazepam—GABRA4—cerebellum—multiple sclerosis	0.000786	0.0231	CbGeAlD
Flunitrazepam—Muscular weakness—Betamethasone—multiple sclerosis	0.000779	0.0068	CcSEcCtD
Flunitrazepam—Muscular weakness—Dexamethasone—multiple sclerosis	0.000779	0.0068	CcSEcCtD
Flunitrazepam—Psychotic disorder—Prednisone—multiple sclerosis	0.000751	0.00656	CcSEcCtD
Flunitrazepam—GABRA1—midbrain—multiple sclerosis	0.000751	0.0221	CbGeAlD
Flunitrazepam—Irritability—Prednisone—multiple sclerosis	0.000734	0.00641	CcSEcCtD
Flunitrazepam—Hypotension—Azathioprine—multiple sclerosis	0.000733	0.0064	CcSEcCtD
Flunitrazepam—GABRA1—spinal cord—multiple sclerosis	0.000732	0.0216	CbGeAlD
Flunitrazepam—GABRA6—brain—multiple sclerosis	0.000726	0.0214	CbGeAlD
Flunitrazepam—Ill-defined disorder—Mitoxantrone—multiple sclerosis	0.000721	0.00629	CcSEcCtD
Flunitrazepam—TSPO—midbrain—multiple sclerosis	0.000719	0.0212	CbGeAlD
Flunitrazepam—Sweating—Methylprednisolone—multiple sclerosis	0.000718	0.00627	CcSEcCtD
Flunitrazepam—GABRA5—brain—multiple sclerosis	0.000704	0.0207	CbGeAlD
Flunitrazepam—TSPO—spinal cord—multiple sclerosis	0.000702	0.0206	CbGeAlD
Flunitrazepam—Malaise—Mitoxantrone—multiple sclerosis	0.000701	0.00612	CcSEcCtD
Flunitrazepam—Asthenia—Cladribine—multiple sclerosis	0.000692	0.00604	CcSEcCtD
Flunitrazepam—CYP2A6—cerebellum—multiple sclerosis	0.00068	0.02	CbGeAlD
Flunitrazepam—Muscular weakness—Prednisone—multiple sclerosis	0.000678	0.00592	CcSEcCtD
Flunitrazepam—Hallucination—Methylprednisolone—multiple sclerosis	0.000669	0.00584	CcSEcCtD
Flunitrazepam—Anxiety—Mitoxantrone—multiple sclerosis	0.000659	0.00576	CcSEcCtD
Flunitrazepam—GABRA3—brain—multiple sclerosis	0.000655	0.0193	CbGeAlD
Flunitrazepam—Discomfort—Mitoxantrone—multiple sclerosis	0.000654	0.00571	CcSEcCtD
Flunitrazepam—Feeling abnormal—Azathioprine—multiple sclerosis	0.000646	0.00564	CcSEcCtD
Flunitrazepam—Confusional state—Mitoxantrone—multiple sclerosis	0.000639	0.00558	CcSEcCtD
Flunitrazepam—GABRA4—brain—multiple sclerosis	0.000639	0.0188	CbGeAlD
Flunitrazepam—GABRA2—nervous system—multiple sclerosis	0.000639	0.0188	CbGeAlD
Flunitrazepam—Dizziness—Cladribine—multiple sclerosis	0.000638	0.00557	CcSEcCtD
Flunitrazepam—Tachycardia—Mitoxantrone—multiple sclerosis	0.000619	0.0054	CcSEcCtD
Flunitrazepam—GABRA1—nervous system—multiple sclerosis	0.000617	0.0182	CbGeAlD
Flunitrazepam—GABRA2—central nervous system—multiple sclerosis	0.000615	0.0181	CbGeAlD
Flunitrazepam—Irritability—Methotrexate—multiple sclerosis	0.000614	0.00536	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.000613	0.00535	CcSEcCtD
Flunitrazepam—Rash—Cladribine—multiple sclerosis	0.000608	0.00531	CcSEcCtD
Flunitrazepam—Hallucination—Betamethasone—multiple sclerosis	0.000608	0.00531	CcSEcCtD
Flunitrazepam—Hallucination—Dexamethasone—multiple sclerosis	0.000608	0.00531	CcSEcCtD
Flunitrazepam—Dermatitis—Cladribine—multiple sclerosis	0.000608	0.00531	CcSEcCtD
Flunitrazepam—Ataxia—Methotrexate—multiple sclerosis	0.000604	0.00528	CcSEcCtD
Flunitrazepam—Headache—Cladribine—multiple sclerosis	0.000604	0.00528	CcSEcCtD
Flunitrazepam—GABRA2—cerebellum—multiple sclerosis	0.000601	0.0177	CbGeAlD
Flunitrazepam—GABRA1—central nervous system—multiple sclerosis	0.000594	0.0175	CbGeAlD
Flunitrazepam—Hypotension—Mitoxantrone—multiple sclerosis	0.000593	0.00517	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Prednisolone—multiple sclerosis	0.000591	0.00516	CcSEcCtD
Flunitrazepam—TSPO—nervous system—multiple sclerosis	0.000591	0.0174	CbGeAlD
Flunitrazepam—Angioedema—Prednisolone—multiple sclerosis	0.000582	0.00509	CcSEcCtD
Flunitrazepam—GABRA1—cerebellum—multiple sclerosis	0.000581	0.0171	CbGeAlD
Flunitrazepam—Malaise—Prednisolone—multiple sclerosis	0.000575	0.00502	CcSEcCtD
Flunitrazepam—TSPO—central nervous system—multiple sclerosis	0.000569	0.0167	CbGeAlD
Flunitrazepam—Somnolence—Mitoxantrone—multiple sclerosis	0.000564	0.00492	CcSEcCtD
Flunitrazepam—TSPO—cerebellum—multiple sclerosis	0.000556	0.0164	CbGeAlD
Flunitrazepam—CYP2A6—brain—multiple sclerosis	0.000552	0.0163	CbGeAlD
Flunitrazepam—Fatigue—Mitoxantrone—multiple sclerosis	0.000547	0.00477	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.000544	0.00475	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.000543	0.00474	CcSEcCtD
Flunitrazepam—Discomfort—Prednisolone—multiple sclerosis	0.000536	0.00468	CcSEcCtD
Flunitrazepam—Angioedema—Triamcinolone—multiple sclerosis	0.000536	0.00468	CcSEcCtD
Flunitrazepam—Angioedema—Methylprednisolone—multiple sclerosis	0.000534	0.00467	CcSEcCtD
Flunitrazepam—Hallucination—Prednisone—multiple sclerosis	0.000529	0.00462	CcSEcCtD
Flunitrazepam—Malaise—Triamcinolone—multiple sclerosis	0.000529	0.00462	CcSEcCtD
Flunitrazepam—Malaise—Methylprednisolone—multiple sclerosis	0.000527	0.00461	CcSEcCtD
Flunitrazepam—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000523	0.00456	CcSEcCtD
Flunitrazepam—Dizziness—Azathioprine—multiple sclerosis	0.000519	0.00453	CcSEcCtD
Flunitrazepam—Tachycardia—Prednisolone—multiple sclerosis	0.000508	0.00443	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000503	0.00439	CcSEcCtD
Flunitrazepam—Anxiety—Methylprednisolone—multiple sclerosis	0.000496	0.00433	CcSEcCtD
Flunitrazepam—Drowsiness—Methotrexate—multiple sclerosis	0.000495	0.00433	CcSEcCtD
Flunitrazepam—Rash—Azathioprine—multiple sclerosis	0.000495	0.00432	CcSEcCtD
Flunitrazepam—Dermatitis—Azathioprine—multiple sclerosis	0.000494	0.00431	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000494	0.00431	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000494	0.00431	CcSEcCtD
Flunitrazepam—Discomfort—Triamcinolone—multiple sclerosis	0.000493	0.00431	CcSEcCtD
Flunitrazepam—Discomfort—Methylprednisolone—multiple sclerosis	0.000492	0.0043	CcSEcCtD
Flunitrazepam—Headache—Azathioprine—multiple sclerosis	0.000491	0.00429	CcSEcCtD
Flunitrazepam—Dry mouth—Triamcinolone—multiple sclerosis	0.000488	0.00426	CcSEcCtD
Flunitrazepam—GABRA2—brain—multiple sclerosis	0.000488	0.0144	CbGeAlD
Flunitrazepam—Angioedema—Dexamethasone—multiple sclerosis	0.000486	0.00424	CcSEcCtD
Flunitrazepam—Angioedema—Betamethasone—multiple sclerosis	0.000486	0.00424	CcSEcCtD
Flunitrazepam—Confusional state—Methylprednisolone—multiple sclerosis	0.000481	0.0042	CcSEcCtD
Flunitrazepam—Malaise—Dexamethasone—multiple sclerosis	0.00048	0.00419	CcSEcCtD
Flunitrazepam—Malaise—Betamethasone—multiple sclerosis	0.00048	0.00419	CcSEcCtD
Flunitrazepam—Sweating—Methotrexate—multiple sclerosis	0.000475	0.00415	CcSEcCtD
Flunitrazepam—GABRA1—brain—multiple sclerosis	0.000472	0.0139	CbGeAlD
Flunitrazepam—Tachycardia—Triamcinolone—multiple sclerosis	0.000467	0.00408	CcSEcCtD
Flunitrazepam—Tachycardia—Methylprednisolone—multiple sclerosis	0.000466	0.00407	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000463	0.00404	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000461	0.00403	CcSEcCtD
Flunitrazepam—Asthenia—Mitoxantrone—multiple sclerosis	0.000455	0.00397	CcSEcCtD
Flunitrazepam—CYP2E1—medulla oblongata—multiple sclerosis	0.000454	0.0134	CbGeAlD
Flunitrazepam—TSPO—brain—multiple sclerosis	0.000452	0.0133	CbGeAlD
Flunitrazepam—Anxiety—Dexamethasone—multiple sclerosis	0.000451	0.00394	CcSEcCtD
Flunitrazepam—Anxiety—Betamethasone—multiple sclerosis	0.000451	0.00394	CcSEcCtD
Flunitrazepam—Discomfort—Betamethasone—multiple sclerosis	0.000447	0.00391	CcSEcCtD
Flunitrazepam—Discomfort—Dexamethasone—multiple sclerosis	0.000447	0.00391	CcSEcCtD
Flunitrazepam—Hypotension—Methylprednisolone—multiple sclerosis	0.000446	0.00389	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Prednisone—multiple sclerosis	0.00043	0.00375	CcSEcCtD
Flunitrazepam—Feeling abnormal—Prednisolone—multiple sclerosis	0.000429	0.00374	CcSEcCtD
Flunitrazepam—Agitation—Prednisone—multiple sclerosis	0.000426	0.00372	CcSEcCtD
Flunitrazepam—Tachycardia—Betamethasone—multiple sclerosis	0.000424	0.0037	CcSEcCtD
Flunitrazepam—Tachycardia—Dexamethasone—multiple sclerosis	0.000424	0.0037	CcSEcCtD
Flunitrazepam—Angioedema—Prednisone—multiple sclerosis	0.000423	0.0037	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.00042	0.00366	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Betamethasone—multiple sclerosis	0.00042	0.00366	CcSEcCtD
Flunitrazepam—Malaise—Prednisone—multiple sclerosis	0.000418	0.00365	CcSEcCtD
Flunitrazepam—Fatigue—Triamcinolone—multiple sclerosis	0.000412	0.0036	CcSEcCtD
Flunitrazepam—Fatigue—Methylprednisolone—multiple sclerosis	0.000412	0.00359	CcSEcCtD
Flunitrazepam—Hypotension—Dexamethasone—multiple sclerosis	0.000406	0.00354	CcSEcCtD
Flunitrazepam—Hypotension—Betamethasone—multiple sclerosis	0.000406	0.00354	CcSEcCtD
Flunitrazepam—CYP2E1—spinal cord—multiple sclerosis	0.000405	0.0119	CbGeAlD
Flunitrazepam—Rash—Mitoxantrone—multiple sclerosis	0.0004	0.00349	CcSEcCtD
Flunitrazepam—Dermatitis—Mitoxantrone—multiple sclerosis	0.000399	0.00349	CcSEcCtD
Flunitrazepam—Headache—Mitoxantrone—multiple sclerosis	0.000397	0.00347	CcSEcCtD
Flunitrazepam—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000394	0.00344	CcSEcCtD
Flunitrazepam—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000393	0.00343	CcSEcCtD
Flunitrazepam—Anxiety—Prednisone—multiple sclerosis	0.000393	0.00343	CcSEcCtD
Flunitrazepam—Discomfort—Prednisone—multiple sclerosis	0.00039	0.0034	CcSEcCtD
Flunitrazepam—Fatigue—Betamethasone—multiple sclerosis	0.000374	0.00327	CcSEcCtD
Flunitrazepam—Fatigue—Dexamethasone—multiple sclerosis	0.000374	0.00327	CcSEcCtD
Flunitrazepam—Tachycardia—Prednisone—multiple sclerosis	0.000369	0.00322	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Prednisone—multiple sclerosis	0.000365	0.00319	CcSEcCtD
Flunitrazepam—CYP2B6—nervous system—multiple sclerosis	0.000364	0.0107	CbGeAlD
Flunitrazepam—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000359	0.00314	CcSEcCtD
Flunitrazepam—Feeling abnormal—Betamethasone—multiple sclerosis	0.000358	0.00312	CcSEcCtD
Flunitrazepam—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000358	0.00312	CcSEcCtD
Flunitrazepam—CYP2B6—central nervous system—multiple sclerosis	0.00035	0.0103	CbGeAlD
Flunitrazepam—Malaise—Methotrexate—multiple sclerosis	0.000349	0.00305	CcSEcCtD
Flunitrazepam—Dizziness—Prednisolone—multiple sclerosis	0.000344	0.003	CcSEcCtD
Flunitrazepam—Asthenia—Triamcinolone—multiple sclerosis	0.000343	0.003	CcSEcCtD
Flunitrazepam—Asthenia—Methylprednisolone—multiple sclerosis	0.000343	0.00299	CcSEcCtD
Flunitrazepam—CYP2E1—nervous system—multiple sclerosis	0.000341	0.01	CbGeAlD
Flunitrazepam—CYP2E1—central nervous system—multiple sclerosis	0.000329	0.00967	CbGeAlD
Flunitrazepam—Rash—Prednisolone—multiple sclerosis	0.000328	0.00286	CcSEcCtD
Flunitrazepam—Dermatitis—Prednisolone—multiple sclerosis	0.000328	0.00286	CcSEcCtD
Flunitrazepam—Fatigue—Prednisone—multiple sclerosis	0.000326	0.00285	CcSEcCtD
Flunitrazepam—Headache—Prednisolone—multiple sclerosis	0.000326	0.00285	CcSEcCtD
Flunitrazepam—Discomfort—Methotrexate—multiple sclerosis	0.000326	0.00284	CcSEcCtD
Flunitrazepam—CYP2E1—cerebellum—multiple sclerosis	0.000321	0.00946	CbGeAlD
Flunitrazepam—Confusional state—Methotrexate—multiple sclerosis	0.000319	0.00278	CcSEcCtD
Flunitrazepam—Dizziness—Triamcinolone—multiple sclerosis	0.000316	0.00276	CcSEcCtD
Flunitrazepam—Dizziness—Methylprednisolone—multiple sclerosis	0.000316	0.00276	CcSEcCtD
Flunitrazepam—Feeling abnormal—Prednisone—multiple sclerosis	0.000312	0.00272	CcSEcCtD
Flunitrazepam—Asthenia—Betamethasone—multiple sclerosis	0.000311	0.00272	CcSEcCtD
Flunitrazepam—Asthenia—Dexamethasone—multiple sclerosis	0.000311	0.00272	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000305	0.00267	CcSEcCtD
Flunitrazepam—Rash—Triamcinolone—multiple sclerosis	0.000302	0.00263	CcSEcCtD
Flunitrazepam—Dermatitis—Triamcinolone—multiple sclerosis	0.000301	0.00263	CcSEcCtD
Flunitrazepam—Rash—Methylprednisolone—multiple sclerosis	0.000301	0.00263	CcSEcCtD
Flunitrazepam—Dermatitis—Methylprednisolone—multiple sclerosis	0.000301	0.00263	CcSEcCtD
Flunitrazepam—Headache—Triamcinolone—multiple sclerosis	0.0003	0.00262	CcSEcCtD
Flunitrazepam—Headache—Methylprednisolone—multiple sclerosis	0.000299	0.00261	CcSEcCtD
Flunitrazepam—Hypotension—Methotrexate—multiple sclerosis	0.000295	0.00258	CcSEcCtD
Flunitrazepam—Dizziness—Betamethasone—multiple sclerosis	0.000287	0.00251	CcSEcCtD
Flunitrazepam—Dizziness—Dexamethasone—multiple sclerosis	0.000287	0.00251	CcSEcCtD
Flunitrazepam—Somnolence—Methotrexate—multiple sclerosis	0.000281	0.00245	CcSEcCtD
Flunitrazepam—CYP2B6—brain—multiple sclerosis	0.000278	0.00818	CbGeAlD
Flunitrazepam—CYP3A4—nervous system—multiple sclerosis	0.000275	0.00808	CbGeAlD
Flunitrazepam—Rash—Dexamethasone—multiple sclerosis	0.000274	0.00239	CcSEcCtD
Flunitrazepam—Rash—Betamethasone—multiple sclerosis	0.000274	0.00239	CcSEcCtD
Flunitrazepam—Dermatitis—Dexamethasone—multiple sclerosis	0.000273	0.00239	CcSEcCtD
Flunitrazepam—Dermatitis—Betamethasone—multiple sclerosis	0.000273	0.00239	CcSEcCtD
Flunitrazepam—Fatigue—Methotrexate—multiple sclerosis	0.000272	0.00238	CcSEcCtD
Flunitrazepam—Headache—Betamethasone—multiple sclerosis	0.000272	0.00237	CcSEcCtD
Flunitrazepam—Headache—Dexamethasone—multiple sclerosis	0.000272	0.00237	CcSEcCtD
Flunitrazepam—Asthenia—Prednisone—multiple sclerosis	0.000271	0.00237	CcSEcCtD
Flunitrazepam—CYP3A4—central nervous system—multiple sclerosis	0.000265	0.00778	CbGeAlD
Flunitrazepam—CYP2E1—brain—multiple sclerosis	0.000261	0.00768	CbGeAlD
Flunitrazepam—Feeling abnormal—Methotrexate—multiple sclerosis	0.00026	0.00227	CcSEcCtD
Flunitrazepam—Dizziness—Prednisone—multiple sclerosis	0.00025	0.00218	CcSEcCtD
Flunitrazepam—Rash—Prednisone—multiple sclerosis	0.000238	0.00208	CcSEcCtD
Flunitrazepam—Dermatitis—Prednisone—multiple sclerosis	0.000238	0.00208	CcSEcCtD
Flunitrazepam—Headache—Prednisone—multiple sclerosis	0.000237	0.00207	CcSEcCtD
Flunitrazepam—Asthenia—Methotrexate—multiple sclerosis	0.000227	0.00198	CcSEcCtD
Flunitrazepam—CYP2B6—Biological oxidations—CYP24A1—multiple sclerosis	0.000221	0.00392	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000218	0.00387	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000218	0.00387	CbGpPWpGaD
Flunitrazepam—CYP2E1—Biological oxidations—CYP27B1—multiple sclerosis	0.000216	0.00384	CbGpPWpGaD
Flunitrazepam—CYP2E1—Biological oxidations—CYP24A1—multiple sclerosis	0.000216	0.00384	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000213	0.00379	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000213	0.00379	CbGpPWpGaD
Flunitrazepam—Dizziness—Methotrexate—multiple sclerosis	0.000209	0.00182	CcSEcCtD
Flunitrazepam—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000209	0.00371	CbGpPWpGaD
Flunitrazepam—Rash—Methotrexate—multiple sclerosis	0.000199	0.00174	CcSEcCtD
Flunitrazepam—Dermatitis—Methotrexate—multiple sclerosis	0.000199	0.00174	CcSEcCtD
Flunitrazepam—Headache—Methotrexate—multiple sclerosis	0.000198	0.00173	CcSEcCtD
Flunitrazepam—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	0.000191	0.0034	CbGpPWpGaD
Flunitrazepam—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	0.000191	0.00339	CbGpPWpGaD
Flunitrazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000189	0.00335	CbGpPWpGaD
Flunitrazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000189	0.00335	CbGpPWpGaD
Flunitrazepam—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000182	0.00323	CbGpPWpGaD
Flunitrazepam—CYP2C19—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000181	0.00322	CbGpPWpGaD
Flunitrazepam—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	0.000179	0.00317	CbGpPWpGaD
Flunitrazepam—GABRA6—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000176	0.00314	CbGpPWpGaD
Flunitrazepam—GABRA4—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000174	0.0031	CbGpPWpGaD
Flunitrazepam—GABRA6—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000173	0.00308	CbGpPWpGaD
Flunitrazepam—GABRA4—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000171	0.00304	CbGpPWpGaD
Flunitrazepam—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	0.00017	0.00302	CbGpPWpGaD
Flunitrazepam—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	0.000169	0.00301	CbGpPWpGaD
Flunitrazepam—CYP2C19—Biological oxidations—CYP27B1—multiple sclerosis	0.000167	0.00296	CbGpPWpGaD
Flunitrazepam—CYP2C19—Biological oxidations—CYP24A1—multiple sclerosis	0.000167	0.00296	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000164	0.00292	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000164	0.00292	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	0.000162	0.00289	CbGpPWpGaD
Flunitrazepam—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000155	0.00276	CbGpPWpGaD
Flunitrazepam—GABRA5—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000155	0.00275	CbGpPWpGaD
Flunitrazepam—GABRA5—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000152	0.0027	CbGpPWpGaD
Flunitrazepam—GABRA3—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000152	0.0027	CbGpPWpGaD
Flunitrazepam—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	0.000152	0.0027	CbGpPWpGaD
Flunitrazepam—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	0.000152	0.0027	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.00015	0.00266	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.00015	0.00266	CbGpPWpGaD
Flunitrazepam—GABRA2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000149	0.00265	CbGpPWpGaD
Flunitrazepam—GABRA3—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000149	0.00265	CbGpPWpGaD
Flunitrazepam—GABRA2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000147	0.00261	CbGpPWpGaD
Flunitrazepam—CYP1A2—Estrogen Receptor Pathway—STAT3—multiple sclerosis	0.000143	0.00255	CbGpPWpGaD
Flunitrazepam—CYP2A6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000143	0.00254	CbGpPWpGaD
Flunitrazepam—CYP1A2—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000141	0.00251	CbGpPWpGaD
Flunitrazepam—GABRA6—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000134	0.00238	CbGpPWpGaD
Flunitrazepam—GABRA6—Neuronal System—BCHE—multiple sclerosis	0.000133	0.00236	CbGpPWpGaD
Flunitrazepam—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	0.000132	0.00235	CbGpPWpGaD
Flunitrazepam—GABRA4—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000132	0.00235	CbGpPWpGaD
Flunitrazepam—GABRA4—Neuronal System—BCHE—multiple sclerosis	0.000131	0.00233	CbGpPWpGaD
Flunitrazepam—CYP1A2—Biological oxidations—CYP27B1—multiple sclerosis	0.00013	0.00231	CbGpPWpGaD
Flunitrazepam—CYP1A2—Biological oxidations—CYP24A1—multiple sclerosis	0.00013	0.00231	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000128	0.00228	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000128	0.00228	CbGpPWpGaD
Flunitrazepam—GABRA1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000127	0.00226	CbGpPWpGaD
Flunitrazepam—GABRA1—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000125	0.00222	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—SRM—multiple sclerosis	0.000125	0.00221	CbGpPWpGaD
Flunitrazepam—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	0.000123	0.00219	CbGpPWpGaD
Flunitrazepam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.00012	0.00213	CbGpPWpGaD
Flunitrazepam—GABRA5—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000117	0.00208	CbGpPWpGaD
Flunitrazepam—GABRA1—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	0.000117	0.00208	CbGpPWpGaD
Flunitrazepam—GABRA5—Neuronal System—BCHE—multiple sclerosis	0.000117	0.00207	CbGpPWpGaD
Flunitrazepam—CYP2A6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000116	0.00206	CbGpPWpGaD
Flunitrazepam—UGT1A3—Biological oxidations—POMC—multiple sclerosis	0.000115	0.00205	CbGpPWpGaD
Flunitrazepam—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000115	0.00205	CbGpPWpGaD
Flunitrazepam—GABRA3—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000115	0.00205	CbGpPWpGaD
Flunitrazepam—GABRA3—Neuronal System—BCHE—multiple sclerosis	0.000114	0.00203	CbGpPWpGaD
Flunitrazepam—GABRA2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000113	0.00201	CbGpPWpGaD
Flunitrazepam—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000113	0.00201	CbGpPWpGaD
Flunitrazepam—GABRA2—Neuronal System—BCHE—multiple sclerosis	0.000112	0.002	CbGpPWpGaD
Flunitrazepam—GABRA1—SIDS Susceptibility Pathways—IL10—multiple sclerosis	0.000112	0.00198	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—SRM—multiple sclerosis	0.000106	0.00188	CbGpPWpGaD
Flunitrazepam—GABRA6—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000106	0.00188	CbGpPWpGaD
Flunitrazepam—GABRA4—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000104	0.00185	CbGpPWpGaD
Flunitrazepam—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.0001	0.00178	CbGpPWpGaD
Flunitrazepam—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.0001	0.00178	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	9.89e-05	0.00176	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	9.89e-05	0.00176	CbGpPWpGaD
Flunitrazepam—UGT2B7—Biological oxidations—POMC—multiple sclerosis	9.82e-05	0.00174	CbGpPWpGaD
Flunitrazepam—GABRA1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	9.66e-05	0.00172	CbGpPWpGaD
Flunitrazepam—GABRA1—Neuronal System—BCHE—multiple sclerosis	9.59e-05	0.0017	CbGpPWpGaD
Flunitrazepam—GABRA6—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	9.35e-05	0.00166	CbGpPWpGaD
Flunitrazepam—CYP2B6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	9.34e-05	0.00166	CbGpPWpGaD
Flunitrazepam—GABRA5—Transmembrane transport of small molecules—AQP4—multiple sclerosis	9.28e-05	0.00165	CbGpPWpGaD
Flunitrazepam—GABRA4—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	9.23e-05	0.00164	CbGpPWpGaD
Flunitrazepam—CYP2E1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	9.15e-05	0.00163	CbGpPWpGaD
Flunitrazepam—GABRA3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	9.11e-05	0.00162	CbGpPWpGaD
Flunitrazepam—GABRA2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	8.95e-05	0.00159	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—CYP27B1—multiple sclerosis	8.78e-05	0.00156	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—CYP24A1—multiple sclerosis	8.78e-05	0.00156	CbGpPWpGaD
Flunitrazepam—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	8.71e-05	0.00155	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—SRM—multiple sclerosis	8.61e-05	0.00153	CbGpPWpGaD
Flunitrazepam—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—multiple sclerosis	8.33e-05	0.00148	CbGpPWpGaD
Flunitrazepam—GABRA5—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	8.2e-05	0.00146	CbGpPWpGaD
Flunitrazepam—GABRA3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	8.05e-05	0.00143	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—GPC5—multiple sclerosis	8.03e-05	0.00143	CbGpPWpGaD
Flunitrazepam—UGT1A1—Biological oxidations—POMC—multiple sclerosis	7.98e-05	0.00142	CbGpPWpGaD
Flunitrazepam—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.94e-05	0.00141	CbGpPWpGaD
Flunitrazepam—GABRA2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	7.91e-05	0.00141	CbGpPWpGaD
Flunitrazepam—GABRA1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	7.63e-05	0.00136	CbGpPWpGaD
Flunitrazepam—UGT1A3—NRF2 pathway—TGFB1—multiple sclerosis	7.59e-05	0.00135	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—CYP27B1—multiple sclerosis	7.47e-05	0.00133	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—CYP24A1—multiple sclerosis	7.47e-05	0.00133	CbGpPWpGaD
Flunitrazepam—Acenocoumarol—ALB—multiple sclerosis	7.34e-05	0.429	CrCbGaD
Flunitrazepam—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	7.06e-05	0.00125	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	6.98e-05	0.00124	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—GPC5—multiple sclerosis	6.83e-05	0.00121	CbGpPWpGaD
Flunitrazepam—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	6.79e-05	0.00121	CbGpPWpGaD
Flunitrazepam—GABRA1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	6.75e-05	0.0012	CbGpPWpGaD
Flunitrazepam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	6.74e-05	0.0012	CbGpPWpGaD
Flunitrazepam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	6.66e-05	0.00118	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—RRM1—multiple sclerosis	6.65e-05	0.00118	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—SRM—multiple sclerosis	6.64e-05	0.00118	CbGpPWpGaD
Flunitrazepam—UGT2B7—NRF2 pathway—TGFB1—multiple sclerosis	6.46e-05	0.00115	CbGpPWpGaD
Flunitrazepam—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.44e-05	0.00114	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	6.4e-05	0.00114	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	6.4e-05	0.00114	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	6.23e-05	0.00111	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	6.2e-05	0.0011	CbGpPWpGaD
Flunitrazepam—CYP2A6—Biological oxidations—POMC—multiple sclerosis	6.15e-05	0.00109	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—CYP27B1—multiple sclerosis	6.07e-05	0.00108	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—CYP24A1—multiple sclerosis	6.07e-05	0.00108	CbGpPWpGaD
Flunitrazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	5.91e-05	0.00105	CbGpPWpGaD
Flunitrazepam—GABRA1—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	5.86e-05	0.00104	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	5.84e-05	0.00104	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	5.84e-05	0.00104	CbGpPWpGaD
Flunitrazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	5.81e-05	0.00103	CbGpPWpGaD
Flunitrazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	5.71e-05	0.00101	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—RRM1—multiple sclerosis	5.66e-05	0.00101	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—GPC5—multiple sclerosis	5.55e-05	0.000986	CbGpPWpGaD
Flunitrazepam—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.5e-05	0.000977	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—SRM—multiple sclerosis	5.36e-05	0.000951	CbGpPWpGaD
Flunitrazepam—UGT1A1—NRF2 pathway—TGFB1—multiple sclerosis	5.25e-05	0.000932	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—SRM—multiple sclerosis	5.25e-05	0.000932	CbGpPWpGaD
Flunitrazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.24e-05	0.00093	CbGpPWpGaD
Flunitrazepam—GABRA6—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	5.07e-05	0.0009	CbGpPWpGaD
Flunitrazepam—GABRA4—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	5e-05	0.000889	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	4.99e-05	0.000886	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	4.99e-05	0.000886	CbGpPWpGaD
Flunitrazepam—CYP2B6—Biological oxidations—POMC—multiple sclerosis	4.96e-05	0.000882	CbGpPWpGaD
Flunitrazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	4.87e-05	0.000865	CbGpPWpGaD
Flunitrazepam—CYP2E1—Biological oxidations—POMC—multiple sclerosis	4.86e-05	0.000864	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	4.85e-05	0.000862	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	4.84e-05	0.00086	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	4.75e-05	0.000843	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—CYP24A1—multiple sclerosis	4.68e-05	0.000831	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—CYP27B1—multiple sclerosis	4.68e-05	0.000831	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—RRM1—multiple sclerosis	4.6e-05	0.000817	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	4.52e-05	0.000803	CbGpPWpGaD
Flunitrazepam—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	4.52e-05	0.000803	CbGpPWpGaD
Flunitrazepam—GABRA5—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	4.45e-05	0.00079	CbGpPWpGaD
Flunitrazepam—Ketazolam—ALB—multiple sclerosis	4.4e-05	0.257	CrCbGaD
Flunitrazepam—GABRA3—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	4.37e-05	0.000776	CbGpPWpGaD
Flunitrazepam—GABRA2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	4.29e-05	0.000762	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—GPC5—multiple sclerosis	4.28e-05	0.00076	CbGpPWpGaD
Flunitrazepam—GABRA1—SIDS Susceptibility Pathways—TNF—multiple sclerosis	4.25e-05	0.000755	CbGpPWpGaD
Flunitrazepam—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.25e-05	0.000754	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—SRM—multiple sclerosis	4.05e-05	0.000719	CbGpPWpGaD
Flunitrazepam—CYP2A6—NRF2 pathway—TGFB1—multiple sclerosis	4.04e-05	0.000719	CbGpPWpGaD
Flunitrazepam—GABRA6—Neuronal System—MAPK1—multiple sclerosis	3.88e-05	0.00069	CbGpPWpGaD
Flunitrazepam—GABRA4—Neuronal System—MAPK1—multiple sclerosis	3.83e-05	0.000681	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—BCHE—multiple sclerosis	3.82e-05	0.000679	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—CYP27B1—multiple sclerosis	3.77e-05	0.00067	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—CYP24A1—multiple sclerosis	3.77e-05	0.00067	CbGpPWpGaD
Flunitrazepam—CYP2C19—Biological oxidations—POMC—multiple sclerosis	3.75e-05	0.000666	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—CYP27B1—multiple sclerosis	3.7e-05	0.000657	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—CYP24A1—multiple sclerosis	3.7e-05	0.000657	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—SRM—multiple sclerosis	3.69e-05	0.000656	CbGpPWpGaD
Flunitrazepam—GABRA1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	3.66e-05	0.00065	CbGpPWpGaD
Flunitrazepam—Clonazepam—ALB—multiple sclerosis	3.55e-05	0.207	CrCbGaD
Flunitrazepam—CYP2A6—Metabolism—RRM1—multiple sclerosis	3.54e-05	0.00063	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—GPC5—multiple sclerosis	3.45e-05	0.000613	CbGpPWpGaD
Flunitrazepam—GABRA1—SIDS Susceptibility Pathways—IL6—multiple sclerosis	3.43e-05	0.000609	CbGpPWpGaD
Flunitrazepam—CYP2C9—Biological oxidations—POMC—multiple sclerosis	3.42e-05	0.000608	CbGpPWpGaD
Flunitrazepam—GABRA5—Neuronal System—MAPK1—multiple sclerosis	3.41e-05	0.000605	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—GPC5—multiple sclerosis	3.38e-05	0.000601	CbGpPWpGaD
Flunitrazepam—GABRA6—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.37e-05	0.000598	CbGpPWpGaD
Flunitrazepam—GABRA3—Neuronal System—MAPK1—multiple sclerosis	3.34e-05	0.000594	CbGpPWpGaD
Flunitrazepam—GABRA4—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.32e-05	0.00059	CbGpPWpGaD
Flunitrazepam—GABRA2—Neuronal System—MAPK1—multiple sclerosis	3.29e-05	0.000584	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—BCHE—multiple sclerosis	3.25e-05	0.000577	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—SRM—multiple sclerosis	3.15e-05	0.00056	CbGpPWpGaD
Flunitrazepam—GABRA5—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.95e-05	0.000525	CbGpPWpGaD
Flunitrazepam—CYP1A2—Biological oxidations—POMC—multiple sclerosis	2.92e-05	0.000519	CbGpPWpGaD
Flunitrazepam—GABRA3—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.9e-05	0.000515	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—RRM1—multiple sclerosis	2.86e-05	0.000508	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	2.85e-05	0.000507	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	2.85e-05	0.000507	CbGpPWpGaD
Flunitrazepam—GABRA2—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.85e-05	0.000506	CbGpPWpGaD
Flunitrazepam—GABRA1—Neuronal System—MAPK1—multiple sclerosis	2.8e-05	0.000498	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—RRM1—multiple sclerosis	2.8e-05	0.000498	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.79e-05	0.000495	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—BCHE—multiple sclerosis	2.64e-05	0.000469	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—GPC5—multiple sclerosis	2.61e-05	0.000463	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	2.6e-05	0.000462	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	2.6e-05	0.000462	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.54e-05	0.000451	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—SRM—multiple sclerosis	2.43e-05	0.000432	CbGpPWpGaD
Flunitrazepam—GABRA1—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.43e-05	0.000432	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—GPC5—multiple sclerosis	2.38e-05	0.000422	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—APOE—multiple sclerosis	2.3e-05	0.000408	CbGpPWpGaD
Flunitrazepam—CYP3A4—Biological oxidations—POMC—multiple sclerosis	2.26e-05	0.000401	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	2.22e-05	0.000395	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	2.22e-05	0.000395	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.17e-05	0.000386	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—RRM1—multiple sclerosis	2.16e-05	0.000384	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—BCHE—multiple sclerosis	2.04e-05	0.000362	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—GPC5—multiple sclerosis	2.03e-05	0.000361	CbGpPWpGaD
Flunitrazepam—UGT1A3—Metabolism—POMC—multiple sclerosis	1.98e-05	0.000351	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—RRM1—multiple sclerosis	1.97e-05	0.00035	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—APOE—multiple sclerosis	1.95e-05	0.000347	CbGpPWpGaD
Flunitrazepam—Diazepam—ALB—multiple sclerosis	1.81e-05	0.106	CrCbGaD
Flunitrazepam—UGT1A3—Metabolism—ALB—multiple sclerosis	1.8e-05	0.00032	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.71e-05	0.000305	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.71e-05	0.000305	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—RRM1—multiple sclerosis	1.68e-05	0.000299	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—POMC—multiple sclerosis	1.68e-05	0.000298	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.68e-05	0.000298	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—BCHE—multiple sclerosis	1.64e-05	0.000292	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—BCHE—multiple sclerosis	1.61e-05	0.000286	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—APOE—multiple sclerosis	1.59e-05	0.000282	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.57e-05	0.000279	CbGpPWpGaD
Flunitrazepam—UGT2B7—Metabolism—ALB—multiple sclerosis	1.53e-05	0.000272	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.53e-05	0.000272	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.44e-05	0.000256	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—POMC—multiple sclerosis	1.36e-05	0.000242	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.31e-05	0.000233	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.31e-05	0.000233	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.31e-05	0.000232	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.3e-05	0.000231	CbGpPWpGaD
Flunitrazepam—UGT1A1—Metabolism—ALB—multiple sclerosis	1.24e-05	0.000221	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.24e-05	0.00022	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—APOE—multiple sclerosis	1.22e-05	0.000218	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.2e-05	0.000213	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—BCHE—multiple sclerosis	1.13e-05	0.000201	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.12e-05	0.000199	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—POMC—multiple sclerosis	1.05e-05	0.000187	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.02e-05	0.000182	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—APOE—multiple sclerosis	9.88e-06	0.000176	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—APOE—multiple sclerosis	9.68e-06	0.000172	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—BCHE—multiple sclerosis	9.67e-06	0.000172	CbGpPWpGaD
Flunitrazepam—CYP2A6—Metabolism—ALB—multiple sclerosis	9.59e-06	0.00017	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—POMC—multiple sclerosis	8.49e-06	0.000151	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—POMC—multiple sclerosis	8.31e-06	0.000148	CbGpPWpGaD
Flunitrazepam—CYP2B6—Metabolism—ALB—multiple sclerosis	7.74e-06	0.000137	CbGpPWpGaD
Flunitrazepam—CYP2E1—Metabolism—ALB—multiple sclerosis	7.58e-06	0.000135	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—APOE—multiple sclerosis	7.47e-06	0.000133	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—BCHE—multiple sclerosis	7.46e-06	0.000133	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—APOE—multiple sclerosis	6.81e-06	0.000121	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—POMC—multiple sclerosis	6.41e-06	0.000114	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—POMC—multiple sclerosis	5.85e-06	0.000104	CbGpPWpGaD
Flunitrazepam—CYP2C19—Metabolism—ALB—multiple sclerosis	5.85e-06	0.000104	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—APOE—multiple sclerosis	5.82e-06	0.000103	CbGpPWpGaD
Flunitrazepam—CYP2C9—Metabolism—ALB—multiple sclerosis	5.33e-06	9.47e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—POMC—multiple sclerosis	5e-06	8.88e-05	CbGpPWpGaD
Flunitrazepam—CYP1A2—Metabolism—ALB—multiple sclerosis	4.56e-06	8.09e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—APOE—multiple sclerosis	4.49e-06	7.98e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—POMC—multiple sclerosis	3.86e-06	6.85e-05	CbGpPWpGaD
Flunitrazepam—CYP3A4—Metabolism—ALB—multiple sclerosis	3.52e-06	6.25e-05	CbGpPWpGaD
